Posted by admin on Aug 7th, 2022
IFM Investors Pty Ltd raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 13.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,737 shares of the medical instruments supplier’s stock after purchasing an additional 4,219 shares during the period. IFM Investors Pty Ltd’s holdings in DENTSPLY SIRONA were worth $1,710,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in XRAY. Ceredex Value Advisors LLC raised its position in shares of DENTSPLY SIRONA by 147.6% in the 4th quarter. Ceredex Value Advisors LLC now owns 3,231,363 shares of the medical instruments supplier’s stock valued at $180,631,000 after purchasing an additional 1,926,113 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of DENTSPLY SIRONA by 16.5% in the 4th quarter. First Eagle Investment Management LLC now owns 7,184,012 shares of the medical instruments supplier’s stock valued at $400,796,000 after acquiring an additional 1,018,179 shares during the last quarter. Select Equity Group L.P. increased its holdings in shares of DENTSPLY SIRONA by 165.7% in the 4th quarter. Select Equity Group L.P. now owns 1,622,532 shares of the medical instruments supplier’s stock valued at $90,521,000 after acquiring an additional 1,011,929 shares during the last quarter. Cooke & Bieler LP increased its holdings in shares of DENTSPLY SIRONA by 37.1% in the 4th quarter. Cooke & Bieler LP now owns 3,525,683 shares of the medical instruments supplier’s stock valued at $196,698,000 after acquiring an additional 953,660 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of DENTSPLY SIRONA by 46.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,940,581 shares of the medical instruments supplier’s stock valued at $164,055,000 after acquiring an additional 936,681 shares during the last quarter. 94.79% of the stock is owned by institutional investors and hedge funds.
Shares of XRAY stock opened at $36.84 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45. DENTSPLY SIRONA Inc. has a 1 year low of $33.78 and a 1 year high of $63.10. The stock has a fifty day moving average of $36.56 and a two-hundred day moving average of $43.90. The firm has a market capitalization of $7.94 billion, a PE ratio of 21.80, a price-to-earnings-growth ratio of 2.89 and a beta of 0.91.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company had revenue of $9.67 billion during the quarter, compared to analyst estimates of $982.05 million. During the same quarter in the previous year, the firm posted $0.72 EPS. The firm’s quarterly revenue was up 841.1% on a year-over-year basis. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 2.41 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 8th. Stockholders of record on Friday, June 24th were issued a $0.125 dividend. The ex-dividend date was Thursday, June 23rd. This represents a $0.50 annualized dividend and a dividend yield of 1.36%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 29.59%.
A number of equities research analysts have recently weighed in on the company. Robert W. Baird downgraded DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $67.00 to $48.00 in a report on Tuesday, April 19th. Piper Sandler lowered their price target on DENTSPLY SIRONA from $41.00 to $38.00 in a report on Monday, July 11th. William Blair downgraded DENTSPLY SIRONA from a “market perform” rating to an “underperform” rating in a report on Friday. Barrington Research lowered their price objective on DENTSPLY SIRONA from $53.00 to $51.00 in a research note on Wednesday, May 11th. Finally, UBS Group upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $58.00 to $47.00 in a research note on Wednesday, June 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $48.11.
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
IFM Investors Pty Ltd Acquires 2,767 Shares of American Financial Group, Inc. (NYSE:AFG)
IFM Investors Pty Ltd Acquires 3,280 Shares of Molson Coors Beverage (NYSE:TAP)